STUDY OF BRONCHIAL REMODELING IN ASTHMA
The CIC-P is conducting a study to measure the effect of Benralizumab (an asthma treatment) on the multiplication of bronchial muscle cells collected during a biopsy.
Location: Centre d'Investigation Clinique Plurithématique (CIC-P) du CHU de Bordeaux - Hôpital Haut-Lévêque Centre François Magendie - G0 - Pessac
Period: Until September 2023
Objectives: Measure the effect of benralizumab on the multiplication of bronchial muscle cells collected during a biopsy.
Profile: Asthmatics and non-asthmatics, men and women aged 18 and over, who never smoked and able to travel to Haut-Lévêque hospital (Pessac).
Study procedure :
1 pulmonology consultation with breath measurement and lung imaging
1 pre-anesthesia consultation
1 outpatient bronchial endoscopy with flexible tube, under general anaesthesia
Duration of participation: 14 days
Compensated participation
Annonce de l'étude
Dernière mise à jour :